The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Radiomic features of renal cell carcinoma primary and metastatic sites as predictors of TERT and BAP1 mutations.
 
Luis A Meza
No Relationships to Disclose
 
Aleksandr Filippov
No Relationships to Disclose
 
Sohaib Naim
No Relationships to Disclose
 
Nazli Dizman
No Relationships to Disclose
 
Alex Chehrazi-Raffle
No Relationships to Disclose
 
Errol James Philip
No Relationships to Disclose
 
Jasnoor Maholtra
No Relationships to Disclose
 
Ramya Muddasani
No Relationships to Disclose
 
Neal Shiv Chawla
No Relationships to Disclose
 
Chi Wah Wong
No Relationships to Disclose
 
Sabrina Salgia
No Relationships to Disclose
 
Misagh Karimi
Honoraria - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Seattle Genetics/Astellas
Consulting or Advisory Role - GlaxoSmithKline
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jeffrey M. Trent
No Relationships to Disclose
 
Sara Ann Byron
No Relationships to Disclose
 
Ammar Chaudhry
No Relationships to Disclose
 
Sumanta K. Pal
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer